560
Views
5
CrossRef citations to date
0
Altmetric
Articles

Long-term retention rate of mepolizumab treatment in severe asthma: a 36-months real-life experience

, MDORCID Icon, , MD, , MD, , BS, , MD, , MD, , MD, , MD, , MD, phd & , MD, phd show all
Pages 158-166 | Received 19 Oct 2021, Accepted 27 Jan 2022, Published online: 12 Feb 2022

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.